Cayuela N, Izquierdo C, Vaquero L, Camara E, Bruna J, Simo M
Neurooncol Adv. 2025; 7(1):vdaf003.
PMID: 39911704
PMC: 11795312.
DOI: 10.1093/noajnl/vdaf003.
Simo M, Rodriguez-Fornells A, Navarro V, Navarro-Martin A, Nadal E, Bruna J
Neurooncol Adv. 2024; 6(1):vdae137.
PMID: 39247496
PMC: 11379916.
DOI: 10.1093/noajnl/vdae137.
Benkhaled S, Schiappacasse L, Awde A, Kinj R
Cancers (Basel). 2024; 16(6).
PMID: 38539428
PMC: 10968598.
DOI: 10.3390/cancers16061093.
Cherng H, Qu M, Zafari Z, Bentzen S, Armstrong T, Gondi V
J Natl Cancer Inst. 2024; 116(6):983-989.
PMID: 38281073
PMC: 11160499.
DOI: 10.1093/jnci/djae020.
Gorter M, Rottgering J, Belgers V, de Witt Hamer P, Douw L, Klein M
Neurooncol Pract. 2023; 10(5):491-492.
PMID: 37720396
PMC: 10502772.
DOI: 10.1093/nop/npad043.
In Regard to Ding et al. 2020: "Managing Cancer and Living Meaningfully (CALM) Intervention on Chemotherapy-Related Cognitive Impairment in Breast Cancer Survivors".
Zarrella G, Braun S
Integr Cancer Ther. 2023; 22:15347354231191706.
PMID: 37605802
PMC: 10467256.
DOI: 10.1177/15347354231191706.
Factors Associated With Neurocognitive Impairment Following Chemoradiotherapy in Patients With High-Grade Glioma: Results of a Prospective Trial.
Sharma P, Medhi P, Kalita A, Bhattacharyya M, Nath J, Sarma G
Brain Tumor Res Treat. 2023; 11(3):183-190.
PMID: 37550818
PMC: 10409617.
DOI: 10.14791/btrt.2023.0004.
Cognitive issues in patients with IDH mutant gliomas: from neuroscience to clinical neuropsychology.
Parsons M, Sabsevitz D
J Neurooncol. 2023; 162(3):525-533.
PMID: 36940053
DOI: 10.1007/s11060-023-04289-4.
Cognitive outcomes after multimodal treatment in adult glioma patients: A meta-analysis.
De Roeck L, Gillebert C, van Aert R, Vanmeenen A, Klein M, Taphoorn M
Neuro Oncol. 2023; 25(8):1395-1414.
PMID: 36809489
PMC: 10398801.
DOI: 10.1093/neuonc/noad045.
Interventions for preventing and ameliorating cognitive deficits in adults treated with cranial irradiation.
Kirkman M, Day J, Gehring K, Zienius K, Grosshans D, Taphoorn M
Cochrane Database Syst Rev. 2022; 11:CD011335.
PMID: 36427235
PMC: 9697842.
DOI: 10.1002/14651858.CD011335.pub3.
The Montreal Cognitive Assessment (MoCA) in neuro-oncology: A pilot study of feasibility and utility in telehealth and in-person clinical assessments.
Jammula V, Rogers J, Vera E, Christ A, Leeper H, Acquaye A
Neurooncol Pract. 2022; 9(5):429-440.
PMID: 36124322
PMC: 9384084.
DOI: 10.1093/nop/npac038.
Quality of Life and Cognitive Function Evaluations and Interventions for Patients with Brain Metastases in the Radiation Oncology Clinic.
Matsui J, Perlow H, Baiyee C, Ritter A, Mishra M, Bovi J
Cancers (Basel). 2022; 14(17).
PMID: 36077835
PMC: 9454858.
DOI: 10.3390/cancers14174301.
The Cognitive Effects of Radiotherapy for Brain Metastases.
Lehrer E, Jones B, Dickstein D, Green S, Germano I, Palmer J
Front Oncol. 2022; 12:893264.
PMID: 35847842
PMC: 9279690.
DOI: 10.3389/fonc.2022.893264.
Mid-term treatment-related cognitive sequelae in glioma patients.
Schlomer S, Felsberg J, Pertz M, Hentschel B, Loffler M, Schackert G
J Neurooncol. 2022; 159(1):65-79.
PMID: 35796933
PMC: 9325813.
DOI: 10.1007/s11060-022-04044-1.
Assessment and Management of Cognitive Function in Patients with Prostate Cancer Treated with Second-Generation Androgen Receptor Pathway Inhibitors.
Wefel J, Ryan C, Van J, Jackson J, Morgans A
CNS Drugs. 2022; 36(5):419-449.
PMID: 35522374
PMC: 9073450.
DOI: 10.1007/s40263-022-00913-5.
Is carotid artery atherosclerosis associated with poor cognitive function assessed using the Mini-Mental State Examination? A systematic review and meta-analysis.
Anbar R, Sultan S, Al Saikhan L, Alkharaiji M, Chaturvedi N, Hardy R
BMJ Open. 2022; 12(4):e055131.
PMID: 35440451
PMC: 9020283.
DOI: 10.1136/bmjopen-2021-055131.
Sociocognitive Functioning and Psychosocial Burden in Patients with Brain Tumors.
Pertz M, Schlegel U, Thoma P
Cancers (Basel). 2022; 14(3).
PMID: 35159034
PMC: 8833643.
DOI: 10.3390/cancers14030767.
Added Value of Cognition in the Prediction of Survival in Low and High Grade Glioma.
van Kessel E, Schuit E, Huenges Wajer I, Ruis C, de Vos F, Verhoeff J
Front Neurol. 2021; 12:773908.
PMID: 34867763
PMC: 8639204.
DOI: 10.3389/fneur.2021.773908.
Preservation of neurocognitive function in the treatment of brain metastases.
Parsons M, Peters K, Floyd S, Brown P, Wefel J
Neurooncol Adv. 2021; 3(Suppl 5):v96-v107.
PMID: 34859237
PMC: 8633744.
DOI: 10.1093/noajnl/vdab122.
The Impact of Stereotactic or Whole Brain Radiotherapy on Neurocognitive Functioning in Adult Patients with Brain Metastases: A Systematic Review and Meta-Analysis.
van Grinsven E, Nagtegaal S, Verhoeff J, van Zandvoort M
Oncol Res Treat. 2021; 44(11):622-636.
PMID: 34482312
PMC: 8686730.
DOI: 10.1159/000518848.
